---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-332982"
form_type: "8-K"
ticker: "LMAT"
cik: "0001158895"
company_name: "LEMAITRE VASCULAR INC"
filed_at: "2026-08-04T20:39:02+00:00"
generated_at: "2026-08-04T20:40:06.341815+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LeMaitre Q2 sales $70.4M (+10%), EPS $0.74 (+23%); Artegraft up 34%; guides FY $276.3M

## Summary
- Sales $70.4M, +10% YoY (+10% organic); EPS $0.74 (+23%).
- Gross margin 72.1% (+210 bps); operating income $20.4M (+26%).
- Artegraft sales +34%; approved in 56 countries, 21% of sales.
- FY guidance: sales mid $276.3M (+11% org), EPS mid $2.89 (+15% GAAP, +21% adj).
- Quarterly dividend $0.25/share payable Sept 3, 2026 to record Aug 20, 2026.

## SEC filing metadata
- accession: 0001193125-26-332982
- form_type: 8-K
- ticker: LMAT
- cik: 0001158895
- company_name: LEMAITRE VASCULAR INC
- filed_at: 2026-08-04T20:39:02+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158895/000119312526332982/0001193125-26-332982-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158895/000119312526332982/d320964d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-332982
- JSON: https://secwatch.observer/filing/0001193125-26-332982.json
- Plain text: https://secwatch.observer/filing/0001193125-26-332982.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.